GE Health Care购买了日本放射制药公司Nihon Medi-Physics的全部所有权。 GE HealthCare buys full ownership of Japanese radiopharmaceutical firm Nihon Medi-Physics.
GEHealth Care正从杉友化学公司购买剩余的50%股份,从而获得日本一家主要放射制药公司Nihon Medi-Physics(NMP)的全部所有权。 GE HealthCare is acquiring full ownership of Nihon Medi-Physics (NMP), a leading Japanese radiopharmaceutical company, by purchasing the remaining 50% stake from Sumitomo Chemical. 这项采购预计将在2025年初结束,但须经监管批准,将加强GE HealthCare在分子成像中的位置,并扩大其在日本的存在。 The acquisition, expected to close in early 2025, subject to regulatory approvals, will enhance GE HealthCare's position in molecular imaging and expand its presence in Japan. NMP的放射药剂在SPECT和PET成像中用于诊断疾病,这项交易将加强GE HealthCare的药物诊断部分。 NMP's radiopharmaceuticals are used in SPECT and PET imaging to diagnose diseases, and the deal will bolster GE HealthCare's Pharmaceutical Diagnostics segment.